Valuation: Pharmesis International Ltd.

Market Cap 13.47M 2.6M 2.02M 1.84M 1.7M 1.53M 2.89M 190M 2.99M 20.4M 8.08M 102M 7.58M 7.42M 322M P/E 2024
11.1x
P/E 2025 -15.3x
Enterprise Value 24.85M 4.81M 3.73M 3.39M 3.13M 2.83M 5.33M 350M 5.52M 37.63M 14.91M 188M 13.99M 13.69M 595M EV / Sales 2024
1.62x
EV / Sales 2025 1.76x
Free-Float
21.36%
Yield 2024 *
-
Yield 2025 -
1 day-8.89%
1 week-8.89%
Current month-18.00%
1 month-13.68%
3 months-34.40%
6 months-77.22%
Current year-78.42%
1 week 0.08
Extreme 0.082
0.09
1 month 0.08
Extreme 0.082
0.1
Current year 0.08
Extreme 0.077
0.42
1 year 0.08
Extreme 0.077
0.42
3 years 0.06
Extreme 0.065
0.7
5 years 0.06
Extreme 0.065
0.7
10 years 0.06
Extreme 0.065
0.7
Manager TitleAgeSince
Chief Executive Officer 63 2017-12-30
Corporate Secretary - -
Corporate Secretary 59 -
Director TitleAgeSince
Chairman 75 2009-01-04
Director/Board Member 63 2004-04-15
Director/Board Member 51 2023-09-30
Change 5-day change 1-year change 3-year change Capi.($)
-8.89%-8.89%-79.75%-6.82% 2.21M
-0.01%+2.36%+41.46%+145.49% 1,286B
-0.34%+0.99%+42.76%+89.82% 688B
+0.36%+1.11%+26.74%+114.47% 521B
+1.14%+2.04%+42.51%+72.81% 386B
-0.89%-1.51%+57.78%+43.65% 364B
+1.27%+1.72%+28.34%+63.11% 302B
+0.37%-0.23%+3.25%+38.05% 287B
+0.25%+0.54%+36.88%+73.88% 252B
+0.60%+0.02%+36.48%+127.27% 208B
Average -0.70%+1.87%+23.64%+76.17% 429B
Weighted average by Cap. +0.12%+3.26%+37.38%+99.59%

Financials

2024 2025
Net sales 67.65M 13.08M 10.15M 9.22M 8.52M 7.69M 14.52M 953M 15.03M 102M 40.59M 511M 38.08M 37.27M 1.62B 43.75M 8.46M 6.56M 5.96M 5.51M 4.98M 9.39M 616M 9.72M 66.25M 26.25M 331M 24.63M 24.1M 1.05B
Net income 8.28M 1.6M 1.24M 1.13M 1.04M 941K 1.78M 117M 1.84M 12.53M 4.97M 62.56M 4.66M 4.56M 198M -4.3M -832K -645K -586K -542K -489K -923K -60.58M -956K -6.51M -2.58M -32.51M -2.42M -2.37M -103M
Net Debt 11.66M 2.25M 1.75M 1.59M 1.47M 1.33M 2.5M 164M 2.59M 17.65M 6.99M 88.12M 6.56M 6.42M 279M 11.38M 2.2M 1.71M 1.55M 1.43M 1.29M 2.44M 160M 2.53M 17.24M 6.83M 86.03M 6.41M 6.27M 273M
Projected Income Statement - Annual - Pharmesis International Ltd.
Logo Pharmesis International Ltd.
Pharmesis International Ltd. is a Singapore-based investment holding company. The principal activities of the Company and its subsidiaries are development, manufacture, packaging and sale of western medicine, traditional Chinese medicine (TCM), health tonic products, wholesale of drugs, raw products, antibiotics and antibiotic agents. Its pharmaceutical products are sold in the People’s Republic of China (PRC). The Company’s segments include Western drugs, TCM formulated drugs, and Distribution. The Western drugs segment refers mainly to chemically formulated drugs marketed under the Kinna brand. The TCM formulated drugs segment refers to traditional Chinese medicine marketed under the Longlife brand. Distribution segment refers to agency products and internally manufactured products which are marketed through the distribution arm. Its subsidiaries include Chengdu Kinna Pharmaceutical Co., Ltd and Sichuan Longlife Pharmaceutical Co., Ltd.
Employees
1,096
Date Price Change Volume
26-11-16 SGD 0.0820 -8.89% 34,200